THY1 and neoplasm: Concerning the liver, the expression of CD90 has been linked to hepatic stem/progenitor cells [14] and, during tumor growth, it has been correlated with an aggressive phenotype [15], and associated with low differentiated HCC and poor prognosis [16–18].